ASP Isotopes (NASDAQ:ASPI) Now Covered by Canaccord Genuity Group

Canaccord Genuity Group assumed coverage on shares of ASP Isotopes (NASDAQ:ASPIFree Report) in a report issued on Friday morning, MarketBeat reports. The firm issued a buy rating and a $4.50 price target on the stock.

Separately, HC Wainwright decreased their price objective on ASP Isotopes from $5.50 to $4.50 and set a buy rating on the stock in a report on Wednesday, August 7th.

Read Our Latest Stock Analysis on ASPI

ASP Isotopes Trading Down 4.5 %

Shares of ASP Isotopes stock opened at $2.96 on Friday. ASP Isotopes has a 1 year low of $0.95 and a 1 year high of $5.67. The company’s fifty day simple moving average is $2.49 and its 200-day simple moving average is $3.30. The company has a market cap of $153.22 million, a price-to-earnings ratio of -5.58 and a beta of 5.11. The company has a current ratio of 4.00, a quick ratio of 4.00 and a debt-to-equity ratio of 2.06.

ASP Isotopes (NASDAQ:ASPIGet Free Report) last announced its quarterly earnings data on Monday, August 19th. The company reported ($0.24) EPS for the quarter. The firm had revenue of $1.02 million for the quarter. As a group, sell-side analysts expect that ASP Isotopes will post -0.24 EPS for the current year.

Insider Buying and Selling at ASP Isotopes

In other news, major shareholder Ak Jensen Investment Managemen acquired 61,849 shares of ASP Isotopes stock in a transaction that occurred on Wednesday, July 10th. The shares were acquired at an average price of $3.40 per share, with a total value of $210,286.60. Following the purchase, the insider now directly owns 6,678,723 shares of the company’s stock, valued at $22,707,658.20. The trade was a 0.00 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 26.30% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the company. Vanguard Group Inc. grew its position in shares of ASP Isotopes by 479.1% in the 1st quarter. Vanguard Group Inc. now owns 1,021,019 shares of the company’s stock valued at $4,217,000 after acquiring an additional 844,705 shares during the period. Marshall Wace LLP lifted its stake in ASP Isotopes by 389.6% in the 2nd quarter. Marshall Wace LLP now owns 545,072 shares of the company’s stock valued at $1,668,000 after purchasing an additional 433,734 shares during the last quarter. Rathbones Group PLC grew its holdings in ASP Isotopes by 27.5% during the second quarter. Rathbones Group PLC now owns 195,915 shares of the company’s stock worth $600,000 after purchasing an additional 42,243 shares during the period. Renaissance Technologies LLC grew its holdings in ASP Isotopes by 5.7% during the second quarter. Renaissance Technologies LLC now owns 171,800 shares of the company’s stock worth $526,000 after purchasing an additional 9,200 shares during the period. Finally, Bank of New York Mellon Corp acquired a new position in ASP Isotopes during the second quarter worth approximately $381,000. 16.80% of the stock is currently owned by institutional investors.

About ASP Isotopes

(Get Free Report)

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.

Featured Articles

Receive News & Ratings for ASP Isotopes Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ASP Isotopes and related companies with MarketBeat.com's FREE daily email newsletter.